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Thursday 13.10.2016 – Official opening of the Congress – Conference room “Sandanski” 
17:00 – 17:15 G. Momekov. Opening Speech. 
17:15 – 17:40 Welcome addresses 
17:40 – 18:15 Platinum sponsor Symposium 
18:15 – 18:55 N. Danchev, A. Stoimenova. Health technology assessment from the BDA and NCPRMP perspective. 
18:55 – 19:20 Golden sponsor Presentation 
20:00 – 22:00 Welcome Reception 
Friday 14.10.2016 
Conference room “Sandanski” Conference room “Blue Hall” 
09:00 – 11:00 Scientific session “Social Pharmacy & Pharmaceutical regulation“ (I) 
 Moderators: Valentina Petkova, Manoela Manova  
09:00 – 09:30 Plenary lecture: A. Cavaco. Social Pharmacy education & research: how can it 
support pharmacy practice? A European perspective.  
09:30 – 09:45 P. Vorobiev, A. Pimenova, L. Krasnova, A. Samoylov. Health innovative 
technology assessment in the Federal Medical Biological Agency of Russia. 
09:45 – 10:00 I. Kovacevska, B. Angelovska, V. Toneva, A. Toneva, Z. Georgiev, I. Kovacevski. 
Assessment in antibiotics self-medication in dental patients. 
10:00 – 10:15 G. Petrova. Generic prescribing or generic dispensing – the shift of the paradigm. 
10:15 – 10:30 I. Getov. Pharmacists’ contribution to improve public health – study of good 
practices within EU. 
10:30 – 10:45 A. Stoimenova, A. Savova, S. Penkov, S. Georgiev. Review of cost containment 
measures for pharmaceuticals in EU. 
10:45 – 10:55 M. Dimitrova, G. Petrova, M. Manova, A. Savova. Modelling costs and results in 
chronic hepatitis C therapy. 
10:55 – 11:00 Discussion 
09:00 – 11:00 Scientific session “Drug design. Biotechnological Drugs & Biosimilars.“ 
Moderators: Irini Doytchinova, Maya Georgieva 
09:00 – 09:30 Plenary lecture: I. Ivanov, G. Nacheva, M. Tileva, E. Krachmarova. Human 
interferon-gamma: a natural model for drug design of new pharmaceuticals for autoimmune 
diseases. 
09:30 – 10:00 Plenary lecture: A. Pesaresi, D. Lamba. Polypharmacology- based strategies in 
Alzheimer’s disease: the Yin and the Yang of acetylcholinesterase inhibition.  
10:00 – 10:20 I. Doytchinova, G. Stavrakov, I. Philipova, M. Atanasova, D. Zheleva. 
Galantamine derivatives as dual-site binding acetylcholinesterase inhibitors. 
10:20 – 10:35 Z. Zhivkova, I. Doytchinova. Quantitative structure-pharmacokinetics 
relationships for acidic and basic drugs. 
10:35 – 10:50 I. Dimitrov, V. Yordanov, I. Doytchinova. EpiTOP 3 – a proteochemometric tool 
for MHC binding prediction. 
 
10:50 – 11:00 Discussion 
 
11:00 – 11:30 Coffee break 11:00 – 11:30 Coffee break 
 
11:30 – 13:00 Scientific session “Social Pharmacy & Pharmaceutical regulation“ (II) 
Moderators: Guenka Petrova, Alexandra Savova 
11:30 – 13:00 Scientific session “Medicinal chemistry and Drug analysis“ 
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11:30 – 11:45 M. Popova, H. Lebanova, A. Stoimenova, I. Getov. 5 years new PV legislation in 
EU – snapshot of direct patients reporting in some member states. 
11:45 – 12:00 V. Petkova, K. Andreevska, D. Grekova, M. Dimitrova, G. Petrova. 
Pharmacotherapy costs of Chronic obstructive pulmonary disease in Bulgaria for the period 
2014-2015. 
12:00 – 12:15 S. Stoev, H. Lebanova, V. Atanasov, I. Getov. Medication errors in real clinical 
practice - an example with case studies of women undergoing assisted reproduction therapy. 
12:15 – 12:25 V. Vodenicharov, K. Mitov. Demographic trends and levels of stress among 
employees in the gambling business. 
12:25 – 12:35 H. Burgazliev. Analysis of some trends in the development of pharmaceutical 
services in the period 1989 - 2015 in Bulgaria and the new challenges facing the sector. 
12:35 – 12:50 Presentation STING PHARMA 
12:50 – 13:00 Discussion 
 
Moderators: Danka Obreshkova, Boyka Tsvetkova 
11:30 – 11:45 L. Andonova, M. Georgieva, Al. Zlatkov. Synthesis, structure evaluation and 
spectral behavior of some N4-substituted aralkylpiperazines with xanthine moiety at N1. 
11:45 – 12:00 M. Georgieva, M. Kaimakanova, W. Hayan, Al. Zlatkov. Prediction of 
pharmacological effects of newly synthesized 8-ethylamino caffeine derivatives, containing a 
substituted arylpiperazine fragment on 8th position. 
12:00 – 12:15 V. Maslarska, L. Peykova. Analytical methods for determination of sildenafil 
citrate in different matrices. 
12:15 – 12:30 I. Pencheva, A. Stoimenova, D. Ilieva-Tonova, V. Maslarska. UV spectral 
fingerprint tests for analysis of antihypertensive drug combinations containing amlodipine. 
12:30 – 12:40 L. Peikova, B. Nikolova-Mladenova, M. Georgieva. Modification and validation of 
RP-HPLC method for stability determination of new benzoylhydrazone at close to 
physiological conditions. 
12:40 – 12:50 T. Dimova. Structural analysis of lyophilized and non-lyophilized sol-gel glasses 
in the system SiO2-CaO-P2O5-Ag2O. 
12:50 – 13:00 Discussion 
13:00 – 14:30 Lunch break 13:00 – 14:30 Lunch break 
Expert panel roundtable: “Clinical pharmacy & Therapeutics“ (I) 
 
Moderators: Georgi Momekov, Borislav Georgiev 
14:30 – 15:00 Plenary lecture: B. Georgiev. Treatment of lipid disorders – conventional, new 
and modern therapy. 
15:00 – 15:30 Plenary lecture: Tsv. Tankova. Diabetes mellitus as a socially significant disease. 
15:30 – 15:45 Presentation NOVO NORDISK PHARMA 
15:45 – 16:00 Discussion 
16:00 – 16:30 Coffee break 
16:30 – 16:50 Plenary lecture: B. Georgiev. Fixed dose combination therapy of cardiovascular 
diseases for primary and secondary prevention. The "polypill" concepts. 
16:50 – 17:05 Presentation PFIZER 
17:05 – 17:15 Discussion 
 
14:30 – 16:30 Scientific session “Medicinal plants, Phytochemistry & Phytotherapy“ 
Moderators: Ilina Krasteva, Niko Benbassat 
14:30 – 15:00 Plenary lecture: F. Bucar. Antibiotic resistance modulation by plant derived 
compounds. 
15:00 – 15:15 R. Gevrenova, K. Bardarov, V. Bardarov, M. Henry. Advances in structure 
elucidation of gotcab saponins from Gypsophila species by high resolution mass spectrometry 
data. 
15:15 – 15:30 Y. Voynikov, D. Jeleva, N. Almoulah, R. Gevrenova. HR-ESI-MS profiling of 
hydroxycinnamic acid amides (HCAAs) in Solanum schimperianum, Hochst. 
15:30 – 15:45 V. Balabanova, A. Vitkova, I. Doytchinova. Bulgaria as a promising source of 
plant substance Arnicae flos. 
15:45 – 16:00 D. Zheleva-Dimitrova, S. Ruseva, V. Lozanov, R. Gevrenova. Analytical profiling 
of bioactive phenolic acids in Geigeria alata (DC) Oliv. & Hiern. by LC/MS and HPLC-UV. 
16:00 – 16:15 A. Shkondrov, M. Kondeva-Burdina, R. Simeonova, V. Vitcheva, I. Krasteva. 
Phytochemical investigation of Astragalus species occurring in Bulgaria. 







16:15 – 16:30 Discussion 
16:30 – 17:00 Coffee break 
17:00 – 17:15 D. Penkov, S. Dimitrova, V. Andonova, E. Milieva, M. Murdjeva, M. Draganov, 
M. Kassarova. Biological activity of total birch leaf extract (Betula pendula, Roth). 
17:15 – 17:45 Discussion 
17:45 – 18:45 Discussion Poster Session I.  
Saturday 15.10.2016 
Conference room “Sandanski” Conference room “Blue Hall” 
09:00 – 11:00 Scientific session “Pharmacology, Toxicology & Drug safety. Nanotoxicology.” 
(I) 
Moderators: Spiro Konstantinov, Vessela Vitcheva 
09:00 – 09:30 Plenary lecture: M. Valoti. Guidelines of Italian nanotoxicology society: 
considerations for in vitro studies. 
09:30 – 10:00 Plenary lecture: P. Perenovska. Pertussis: current immunization practices. 
10:00 – 10:15 V. Tzankova, Y. Yordanov, D. Aluani, M. Kondeva-Burdina, K. Yoncheva. 
Nanotoxicology and safety assessment of nanoscale drug delivery systems. 
10:15 – 10:30 S. Konstantinov, G. Momekov, M. Zaharieva, M Berger. Oncopharmacological 
studies with clinical relevance for the hematological and oncological practice. 
10:30 – 10:40 P. Gateva, V. Angelova, N. Vasilev, S. Surcheva, J. Voynikov, J. Tchekalarova. 
Newly synthesized coumarin and 2h-chromene derivatives of hydrazide hydrazones with 
promising anticonvulsant activity and lacking minimal toxicity. 
10:40 – 10:50 A. Kasabova, M. Kondeva-Burdina, J. Mitkov, M. Georgieva, V. Tzankova, A. 
Zlatkov. Comparative study of newly synthesized derivatives of caffeine-8-thioglycolic acid on 
isolated rat hepatocytes. 
10:50 – 11:00 Discussion 
 
09:00 – 11:00 Scientific session “Drug delivery systems. Nanopharmaceutics - I“ 
Moderators: Milen Dimitrov, Denitsa Momekova 
09:00 – 09:30 Plenary lecture: G. Storm. Theranostics in Targeted Nanomedicine Development. 
09:30 – 09:40 D. Momekova, D. Babikova, R. Kalinova, I. Zhelezova, G. Momekov, S. 
Konstantinov, I. Dimitrov. Design of polymeric nanocarriers for targeted intracellular delivery 
of curcumin. 
09:40 – 09:55 A. Aleksiev, B. Kostova, D. Rachev. Obtaining of coated pellet galantamine 
hydrobromide delivery systems - design of experiment. 
09:55 – 10:10 K. Yoncheva, B. Tzankov, Y. Yordanov, V. Tzankova, N. Lambov. 
Biopharmaceutical and toxicological aspects of mesoporous silica nanosized drug delivery 
systems. 
10:10 – 10:25 E. Drakalska, D. Momekova, D. Bodurova, S. Rangelov, N. Lambov. Preparation 
and characterization of curcumin loaded hybrid pH-sensitive liposomes. 
10:25 – 10:35 B. Kostova, E. Kamenska, D. Georgieva, K. Balashev, D. Rachev, G. Georgiev. 
Synthesis and characterization of polyzwitterionic copolymer microgel drug delivery systems. 
10:35 – 10:45 P. Bakardzhiev, D. Momekova, K. Edwards, S. Konstantinov, S. Rangelov. 
Polyglycidol is a promising candidate for steric stabilization of liposomes. 
10:45 – 11:00 Discussion 
11:00 – 11:30 Coffee break 11:00 – 11:30 Coffee break 
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11:30 – 13:00 Scientific session “Pharmacology, Toxicology & Drug safety. Nanotoxicology.” 
(II) 
Moderators: Magdalena Kondeva-Burdina, Rumyana Simeonova 
11:30 – 11:45 M. Kondeva-Burdina, S. Valcheva-Kuzmanova, Ts. Мarkova, M. Mitcheva, M. 
Belcheva. Study on the effects of total extract from Aronia melanocarpa on isolated rat 
hepatocytes. 
11:45 – 12:00 M. Kondeva-Burdina, V. Tzankova, A. Kasabova, Z. Kokanova-Nedialkova, M. 
Georgieva, J. Mitkov, P. Nedialkov, I. Krasteva, A. Zlatkov. Evaluation of the neuroprotective 
effects of biologically active substances from natural and synthetic origin. 
12:00 – 12:10 D. Aluani, V. Batchev, V. Tzankova, M. Kondeva-Burdina, K. Yoncheva. 
Protective effects of quercetin nanoformulation in a microsomal model of lipid peroxidation. 
12:10 – 12:20 Y. Yordanov, V. Tzankova, M. Valoti, M. Frosini, B. Kostova, M. Kyulavska, L. 
Todorova, D. Christova. In vitro toxicity evaluation of block copolymers containing cationic 
blocks in HEPG2 cells. 
12:20 - 12:30 N. Agova, S. Georgieva, Y. Koleva, M. Todorova. Probable hepatotoxic action of 
bexarotene. 
12:30 – 12:40 N. Agova, S. Georgieva, Y. Koleva, M. Todorova. Effect of metabolic activation of 
several bexarotene analogues. 
12:40 – 13:00 Discussion 
 
11:30 – 13:00 Scientific session “Drug delivery systems. Nanopharmaceutics - II“ 
Moderators: Dimitar Rachev, Krassimira Yoncheva 
 
11:30 – 12:00 Plenary lecture: P. Petrov, K. Yoncheva, D. Momekova, G. Grancharov, V. 
Gancheva, M. Kyulavska, G. Momekov, S. Konstantinov, B. Trzebicka. Functional multilayer 
polymeric nanocarriers of anticancer agents.  
12:00 – 12:10 M. Slavkova, G. Petrovick, M. Dimitrov, J. Breitkreutz. Design and optimization of 
solid lipid pharmaceutical pellets for taste masking and immediate release of phenobarbital. 
12:10 – 12:20 Y. Yildirim, M. Simeonov, H. Tsachev, E. Vasileva. Poly (methacrylic acid)/ 
polydimethylacrylamid hydrogel interpenetrating polymer networks – synthesize, properties 
and use as release drug delivery systems. 
12:20 - 12:30 N. Ivanova, St. Titeva, C. DiFranco, A. Trapani. Investigation of technological 
factors in the process of preparation of diltiazem loaded EUDRAGIT RS 100 
“MICROSPONGES“. 
12:30 – 12:40 Z. Vinarov, D. Radeva, S. Tcholakova, N. Denkov. Micellar solubilization of 
hydrophobic drugs. 
12:40 – 12:50 G. Bocheva, M. Valcheva-Traykova. Application of nanomaterials in cosmetics. 
12:50 – 13:00 Discussion 
13:00 – 14:30 Lunch break 13:00 – 14:30 Lunch break 
Expert panel roundtable: “Clinical pharmacy & Therapeutics“ (II) 
 
Moderators: Georgi Momekov, Rumyana Simeonova 
14:30 – 15:00 Plenary lecture: B. Georgiev. Antihypertensive therapy – principals of drug 
therapy. Are all drugs in a class are equivalent in comorbidities? 
15:00 – 15:30 Plenary lecture: D. Petrova, V. Pencheva, О. Georgiev, B. Stancheva, Y. Dimitrov. 
Recommendations for the treatment of stable COPD and reality in Bulgarian patients. 
15:30 – 16:00 Coffee break 
16:00 – 16:20 Plenary lecture: M. Stoyanov. Choice of therapy in patients with Heart Failure. 
16:20 – 16:40 Plenary lecture: M. Stoyanov. Antiarrhythmic drugs – classification and clinical 
application. Antiarrhythmic therapy in Bulgaria. 
16:40 – 16:55 L. Marinov, I. Nikolova, N. Danchev. Rheumatoid arthritis – new therapeutic 
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approaches. 
16:55 – 17:10 Presentation BOEHRINGER-INGELHEIM 
17:10 – 18:10 Discussion Poster Session II.  
20:00 Gala Dinner 
Sunday 16.10.2016 
09:30 – 10:00 Official closing session of the Congress  
 
POSTER SESSION 
Committee: Georgi Momekov, Guenka Petrova, Alexander Zlatkov, Paraskev Nedialkov, Dimitar Rachev, Irini Doytchinova 
Poster session I – 14.10.2016  Poster session II – 15.10.2016 
1. M. Zeković, D. Krajnović, V. Marinković, T. Stojković, Lj. Tasić. Аdherence in community 
Pharmacies: Pharmacits’ beliefs, attitudes and professional practice. 
2. T. Stojković, V. Marinković, D. Krajnović, M. Zeković, Lj. Tasić. Risk management of the 
medicines dispensing process in community pharmacy. 
3. A. Borisova, V. Getova, D. Petrova, H. Slaveykova, M. Popova, Dynamics in the reporting of 
adverse reactions in the republic of Bulgaria between 2010 – 2015. 
4. A. Todorova, A. Cvetkova, M. Arnaudova , K. Andreevska, D. Dimitrov. Pharmacist`s role 
for the improvement of quality of life in patients with seasonable allergic rhinitis. 
5. Hr. Burgazliev, Zl. Dimitrova, V. Petkova, D. Grekova, K. Andreevska. Origin and 
development of the private concession pharmacy, branches and temporary pharmacies in the 
Bourgas region for the period 1978-1949. 
6. Hr. Burgazliev, St. Gueorguiev, V. Madjarov, R. Kiskinova, Zl. Dimitrova. State of the 
pharmaceutical services in Bourgas region and recommendations for development. 
7. B. Hadzhieva, D. Obreshkova, M. Dimitrov, V. Petkova. Analysis of consumer attitudes 
towards some omega unsaturated fatty acids in food additives. 
8. V. Belcheva, E. Grigorov. Health economic impact of some major Rx-to-OTC switches in 
Bulgaria. 
9. V. Getova, A. Borisova, D. Petrova, J. Eftimov, M. Popova. Analysis of the distributed direct 
communications and educational materials aiming at adverse drug reactions (ADR) risk 
46. L. Marinov, A. Shkondrov, I. Nikolova, I. Krasteva, P. Zdraveva, N. Danchev. The effect of 
Gypsophila extract in collagen-induced arthritis in mice. 
47. D. Zheleva-Dimitrova, S. Bouguet-Bonnet, S. Poinsignon, J-B Regnouf De Vains, M. Mourer, 
R. Gevrenova, M. Henry. New approach in triterpene saponin purification. 
48. Z. Kokanova-Nedialkova, P. Nedialkov. Radical-scavenging activities of nine flavonoids 
isolated from the aerial parts of Chenopodium bonus-henricus L. 
49. I. Mincheva, N. Benbassat, D. Butovska, A. Stoyanova, E. Kozuharova. Lipophilic extracts 
from Potentilla reptans L. (Rosaceae). 
50. N. Benbassat, T. Cherneva, N. Avakumova, V. Hadjimitova, K.  Yoncheva. Evaluation of 
antioxidant activity of extract and oil prepared form Illicium verum. 
51. P. Nedialkov, Y. Ilieva, I. Zhelyazkov. Phytochemical study on the methanol extract of 
Hypericum cerastoides. 
52. L. Dimitrova, M. Zaharieva, M. Popova, I. Tsvetkova, S. Konstantinov, V. Bankova, H. 
Najdenski. Investigation of extracts and compounds derived from the plant Geum urbanum L. for 
antimicrobial and cytotoxic potential. 
53. Y. Ilieva, P. Nedialkov, G. Momekov. Major cytotoxic acylphloroglucinols from Hypericum 
olympicum L. 
54. M. Simeonov, B. Kostova, E. Vassileva. Drug delivery systems based on hydrogels of 
acrylate and methacrylate interpenetrating polymer networks. 
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minimization for the period 2013-2015. 
10. M. Kamusheva, G. Petrova. Cost-utility analysis of therapy for breast cancer – a case with 
trastuzumab emtansine. 
11. K. Mitov, M. Kamusheva, G. Petrova. Application of meta-analysis for determining the 
cost-effectiveness of adalimumab citrate free formulation. 
12. Hr. Burgazliev, Zl. Dimitrova, V. Petkova, K. Andreevska, D. Grekova. The origin and 
development of the concession communal and   institutional pharmacies in the region of 
Bourgas for the period 1978-1949. 
13. A. Zlatareva, T. Kostadinova, G. Petrova. Why are increased the cost of drug therapy of 
oncologic diseases? 
14. A. Savova, Z. Mitkova, B. Zidarova, M. Vasileva, M. Manova, N. Danchev. Analysis of the 
changes in reference value, paid with public funds after exclusion of medicinal products from 
positive drug list. 
15. Zh. Kolev, Е. Grigorov. The role of generic medicines for limiting of pharmaceutical 
expences. 
16. S. Galeva, Е. Grigorov. The electronic prescription in Sweden. 
17. M. Doneva, M. Kamusheva, M. Dimitrova, V. Petkova, G. Petrova, D. Petrova, O. Georgiev. 
Analysis of demographic characteristics and severity of COPD in Bulgaria. 
18. G. Petrova, M. Manova, Z. Mitkova. Utilization of cardiovascular medicines in reference 
DDD/1000INH/DAY. 
19. S. Krumov, N. Angelova, V. Pandov, I. Getov. Building a prognostic model for availability 
of master pharmacists over medium term in Bulgaria.  
20. S. Krumov, I. Getov. Methodological approach for implementation of electronic platform 
for visualization of pharmacies in Bulgaria and analysis of accessibility to pharmacy services.  
21. M. Drenska, I. Getov. Research of approaches for regulation of off-label use of medicinal 
products in European Union. 
22. N. Marchokova, V. Petkova, M. Dimitrov. Specifics of patent law in Bulgaria, Europe, 
Japan, USA and Canada in respect of medicines. 
23. N. Gerasimov, G. Petrova. Legal, economic and ethical aspects regarding the regulation of 
medical devices for rare disease in Europe. 
24. B. Angelovska, S. Stojkov, Z. Binakaj, E. Drakalska. Counterfeit medicines and availability 
to patients in Republic of Macedonia, Serbia and Bosnia and Herzegovina. 
25. V. Petkova, I. Jancheva, K. Andreevska, D. Grekova, M. Dimitrov. Assessment of quality of 
life in patients with polycystic ovary syndrome. 
26. V. Petkova, M. Konova, K. Andreevska, D. Grekova, M. Dimitrov. Evaluation of quality of 
life in patients with rheumatoid arthritis. 
55. B. Tzankov, K. Yoncheva, N. Lambov. Evaluation of pramipexole-loading into hollow 
mesoporous silica particles. 
56. V. Karabelyov , V. Angelova, Y. Chekalarova. Current development of 
hydrazide/hydrazone derivatives and structural analogues as anticonvulsants in animal 
models. 
57. V. Andonova, P. Peneva, G. Georgiev, D. Penkov, M. Kassarova. Bigels with ketoprofen-
loaded polymer nanoparticles. 
58. V. Kavlakova-Nazarova, M. Kassarova, A. Stoimenova, P. Kavlakov, K. Valiov. Devices 
providing preparation for sterile medicinal products with toxic potential for parenteral 
administration. 
59. M. Dobreva, V. Gugleva, St. Titeva. In-vitro release studies of indometacin–loaded 
microspheres from different dermal dosage forms. 
60. M. Dundarova, B. Kostova, V. Tsankova, K. Ivanova-Mileva, D. Georgieva, D. Rachev, D. 
Christova. Design and study of the potential of hydrogel networks as drug delivery systems 
for dermal application. 
61. S. Stefanov, St. Titeva. Preparing tablet formulations with lithium carbonate with a 
sustained action for the prevention and treatment of bipolar disorder. 
62. M. Petrov, V. Petrova. The research of the principle of Pareto in the pharmaceutical activity. 
63. P. Peneva, V. Andonova, M. Kassarova. Rheological and biopharmaceutical study of 
emulgels with ketoprofen. 
64. P. Katsarov, B. Pilicheva, G. Gergov, M. Kassarova. Polymer microspheres with doxylamine 
and pyridoxine – challenges in incorporating the drug combination. 
65. B. Gjorgjeska, S. Petkovska. Comparison of the dissolution test for solid dosage forms in 
different pharmacopoeia. 
66. L. Krasnova, P. Vorobiev, I. Tyurina. Clinical and economic analysis of two surfactants for 
the prevention and treatment of respiratory distress syndrome. 
67. J. Brkic, Lj. Tasic, V. Marinkovic. Potentially inappropriate benzodiazepine use in elderly 
living in long-term care institutions in Serbia: a pilot study. 
68. L. Zylbeari, N. Behxheti, Z. Bexheti, G. Zylbeari, K. Cakalarovski. The effects of 
erythropoesis stimulating agent on management the renal anemia in uremic patients. 
69. L. Zylbeari, N. Behxheti, K. Çakalarovski, G. Zylbeari, Z. Bexheti. Managing of 
Dyslipidemia in Uremic patients with Statins. 
70. A. Mihaylova, E. Uchicova, N. Parahuleva, S. Gueorgiev. Medical social aspects of 
surfactant therapy in premature newborns. 
71. A. Trochopoulos, P. Donchev, K. Kaloyanov, I. Pencheva, P. Petrov, K. Yoncheva, S. 
Konstantinov. New micellar curcumin form with antineoplastic activity in myeloma and 
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27. Hr. Burgazliev, St. Gueorguiev, V. Madzharov, R. Kiskinova, Zl. Dimitrova. Establishment 
and development of drug stores in Bourgas region for the period between 1878–1947. 
28. M. Ganeva, T. Gancheva, J. Troeva, D. Gancheva, E. Hristakieva. Adverse drug reactions 
and self-medication. 
29. S. Zafiroski, I. Kumanov, S. Georgieva. Herbal supplements in dental surgery. 
30. B. Nikolova-Mladenova, G. Momekov, D. Ivanov. Gallium(III) complexes with bioactive 
ligands 5-methoxysalicylaldehyde benzoylhydrazone and 5-methoxysalicylaldehyde 
isonicotinoylhydrazone. 
31. V. Angelova, V. Valcheva, Y. Voynikov, N. Vassilev. Synthesis and antimycobacterial 
activity of coumarin-based hydrazones and chromen[4,3-c]pyrazol-4-ones. 
32. E. Cherneva, R. Buyukliev, A. Bakalova. Synthesis, spectral investigation and quantum 
chemical study of Pt(II) complex with 3'-amino-2-indanespiro-5'-hydantoin. 
33. I. Valkova, I. Dimitrov, Zv. Zhivkova, I. Doytchinova. Isothermal titration calorimetry 
study of the acetylcholine esterase inhibitor galanthamine. 
34. I. Valkova, L. Antonova, M. Kondeva-Burdina, M. Dimitrova, A. Zlatkov. Quantitative 
structure – hepatotoxicity relationships of arylpiperzine derivatives. 
35. M. Atanasova, P. Sasheva, I. Yonkova, I. Doytchinova. Modelling the interaction and 
prediction of microtubule assembly inhibition of podophyllotoxin and its derivatives via 
molecular docking. 
36. S. Bozhanov, V. Maslarska, B. Tsvetkova, L. Peykova. Determination of metronidazole in 
tablet dosage forms by high performance liquid chromatographic method. 
37. A. Bakalova, E. Cherneva, Y. Rusenova, P. Arnaudov, T. Atanasova, I. Zhelezova, S. 
Konstantinov. New mixed ammine/amine platinum complexes with 3'-amino-4-thiо-1h-
tetrahydropyranspiro-5'-hydantoin. Preparation, spectral analysis, theoretical calculations and 
biological properties. 
38. V. Maslarska, S. Bozhanov,  L. Peikova. Simultaneous determination of ketoprofen and 
omeprazole in laboratory mixture by high pressure liquid chromatographic method. 
39. V. Maslarska, V. Yankov, D. Obreshkova, S. Bozhanov. High pressure liquid 
chromatographic method for simultaneous determination of some sartans. 
40. R. Buyukliev, D. Dimitrova. Synthesis of some new 3-amino-5,5-disubstituted hydantoins. 
41. L. Raev, I. Ivanov. Addition of 6-amino-4-aryl-2(1h)-pyridines to phenyl isocyanate and 
related reactions. 
42. D. Obreshkova, D. Tsvetkova, S. Ivanova. Quality control of tablets containing estradiol 
valeratе by densitometric method. 
43. B. Nikolova-Mladenova, G. Momekov, G. Mitev, D. Ivanov. Synthesis, spectral 
characterization and cytotoxic activity of new 5-methoxy-derivatives of salicylaldehyde 
benzoylhydrazone. 
leukemia cells. 
72. N. Hristova-Avakumova, B. Nikolova-Mladenova, V. Hadjimitova, K. Yoncheva, N. 
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